ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2018

Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study.

Cristina Scavone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.